Galaxy Pharmaceuticals, LLC
FDA 503B outsourcing facility
Albany, New York
Key Takeaways
- FDA-registered 503B outsourcing facility since 2024
- Sterile compounding from bulk substances: Yes
- Not yet inspected by the FDA
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- January 26, 2024
- Most recent registration
- November 26, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- Not yet inspected
Galaxy Pharmaceuticals, LLC has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
Compounded peptides and GLP-1s
Galaxy Pharmaceuticals, LLC has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
15 Walker Way, Albany, NY 12205
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Dalbir Bains, 1-646-957-7762. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Galaxy Pharmaceuticals, LLC with the New York State Board of Pharmacy.
503B facilities in New York
New York has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in New York.
Frequently asked questions
Is Galaxy Pharmaceuticals, LLC registered with the FDA?
Yes. Galaxy Pharmaceuticals, LLC is a registered 503B outsourcing facility, first registered with the FDA on January 26, 2024 and most recently registered on November 26, 2025.
Has Galaxy Pharmaceuticals, LLC been inspected by the FDA?
Galaxy Pharmaceuticals, LLC has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has Galaxy Pharmaceuticals, LLC had any FDA drug recalls?
No FDA drug recalls are matched to Galaxy Pharmaceuticals, LLC in the openFDA enforcement database.
What does Galaxy Pharmaceuticals, LLC compound?
Galaxy Pharmaceuticals, LLC has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Galaxy Pharmaceuticals, LLC located?
Galaxy Pharmaceuticals, LLC is located in Albany, New York (15 Walker Way).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Galaxy Pharmaceuticals, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.